Jodi Warman Chardon
Clinician-Scientist, The Ottawa Hospital; Associate Scientist, OHRI; Scientist, CHEORI; Associate Professor of Neurology, University of Ottawa
Director, NeuroMuscular Centre, The Ottawa Hospital; Co-Director, uOBMRI Centre for Neuromuscular Disease
NMD4C Working Group(s): Biobanking, Early CareerEmail Jodi
Dr. Jodi Warman Chardon is a Clinician-Scientist in the Department of Medicine at the Ottawa Hospital, Ottawa Hospital Research Institute (OHRI) in Neurosciences and Clinical Epidemiology and Department of Genetics at the Children’s Hospital of Eastern Ontario/CHEO RI. She is a Tier 2 Clinical Research Chair in Diagnosis and Discovery Pipeline for Patients with Genetic Neuromuscular Disease and Associate Professor of Neurology at University of Ottawa. She led the strategic development and is now Director of the Ottawa Hospital Neuromuscular Centre, a diagnostic clinical research centre for patients with NMD. She is also co-director (with Dr Robin Parks) of the uOttawa Centre for Neuromuscular Disease, which unites over 60 clinical and basic NMD researchers.
Dr. Warman received her MD/Neurology residency at the University of Ottawa and MSc from Queen’s University. She completed research and clinical fellowships in neuromuscular disorders from McGill University and neurogenetics at the University of Ottawa and is certified by the Canadian Society of Clinical Neurophysiologists (EMG).
Dr. Warman’s clinical research focuses on improved genomic and imaging studies for patients with inherited myopathies and neuromuscular disorders. She represents adult NMDs as a member of the NMD4C Steering Committee and will ensure that the next generation of NMD scientists and clinicians is engaged in all activities of the work plan. She participates in genomics education for the network, leading on engaging trainees and early-career researchers.
Thebault, S, Warman-Chardon, J, O'Connell, K, Miller, WD, Bourque, PR. Isolated Internuclear Ophthalmoplegia as an Embolic Complication of Transcatheter Aortic Valve Implantation. Cureus. 2022.14 (12)e32292 PMID:36514705
Melkus, G, Sampaio, ML, Smith, IC, Rakhra, KS, Bourque, PR, Breiner, A et al.. Quantitative vs qualitative muscle MRI: Imaging biomarker in patients with Oculopharyngeal Muscular Dystrophy (OPMD). Neuromuscul Disord. 2023.33 (1)24-31 PMID:36462961
Hartley, T, Soubry, É, Acker, M, Osmond, M, Couse, M, Gillespie, MK et al.. Bridging clinical care and research in Ontario, Canada: Maximizing diagnoses from reanalysis of clinical exome sequencing data. Clin Genet. 2023.103 (3)288-300 PMID:36353900
Lee, MM, McDowell, GSV, De Vivo, DC, Friedman, D, Berkovic, SF, Spanou, M et al.. The clinical spectrum of SMA-PME and in vitro normalization of its cellular ceramide profile. Ann Clin Transl Neurol. 2022.9 (12)1941-1952 PMID:36325744
Schiava, M, Ikenaga, C, Villar-Quiles, RN, Caballero-Ávila, M, Topf, A, Nishino, I et al.. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study. J Neurol Neurosurg Psychiatry. 2022. PMID:35896379See more on PubMed